Xenotransplantation reached a milestone when a gene-edited pig kidney was placed in a living person. Surgeons in 2024 transplanted the organ into a patient with kidney failure. It extended earlier work done only in brain-dead recipients.
Gene-edited organ
Editing enables it. Dozens of genetic changes reduce rejection and viral risk. The donor pig is engineered.
A living recipient
The step is new. Earlier trials used brain-dead bodies for study. This patient was alive.
Organ shortage
The motive is stark. Thousands die waiting for transplants each year. Animal organs could help.
Rejection risk
Vigilance is required. The immune system still threatens the graft. Careful drugs are needed.
Early days
Caution applies. Long-term survival remains unproven. Follow-up is essential.
A regulated path
Trials loom. Formal clinical studies are being designed. The field is advancing carefully.
The bottom line
Surgeons transplanted a gene-edited pig kidney into a living patient, extending xenotransplantation beyond earlier studies. It targets the organ shortage. Long-term outcomes remain to be proven.
